|
Have You Entered Our Mercedes Giveaway?
You can win. You can win a cruise. A shopping spree. And of course, the grand prize, a 2014 Mercedes-Benz!  Click Here to learn more and find out how to get your tickets.
Tickets are $75 per ticket, $200 for 3, or $300 for 5 tickets.
Two early birds: buy your tickets early to get a shot at also winning:
A cruise
A shopping spree
And you can do it all while helping keep alive critical programs for patients and a highly functional information hub for lupus alive.
Get your tickets now.
|
Information contained in this e-Newsletter should not be considered a substitute for professional diagnosis, treatment or management of S.L.E. and symptoms by a physician.
Missed a previous issue of this e-Newsletter?
You can now view our ARCHIVES.
Editor: Spandan Chakrabarti
|
|
Connect with us on
via "Lupus Online"
|
|
LFNC is an active partner in
|
LFNC's Social Media Program is funded through a generous grant from THE HENRY L. GUENTHER FOUNDATION GEORGE H. SANDY FOUNDATION GLAXOSMITHKLINE |
|
|
|
|
You are receiving this newsletter because you have subscribed or have participated in our programs or events. We respect your time and privacy. If you prefer not to continue receiving the newsletter, you can click on the "safe unsubscribe" button below. We hope, however, that you will opt to remain on our newsletter list for important information and life-saving tips that you or someone you know may benefit from now or in the future.
|
|
Spice that Gives Mustard its Color Shown to Help with Lupus
 An Indian Turmeric plant.
Turmeric is a spice commonly used in Indian and some other Asian cuisines. In those cultures, it's always been hailed as a ailment deterrent, but now scientists have proof of just that. Researchers at Cytokine Research Laboratory of the University of Texas M.D. Anderson Cancer Center in Houston found that the spice may be an effective antidote to lupus, certain forms of cancer, and diabetes.
Cell-based studies have demonstrated the potential of turmeric as an anti-microbial, insecticidal, larvicidal, anti-mutagenic, radioprotector and anti-cancer agent, the researchers said.
Numerous animal studies showed the potential of this spice against pro-inflammatory diseases such as cancer, neurodegenerative diseases, depression, diabetes, obesity and atherosclerosis, the researchers said.
In clinical trials, turmeric showed some effectiveness against numerous human ailments, including lupus, cancer, diabetes, irritable bowel syndrome, acne and fibrosis.
Read more about the study here.
|
|
Pencil in January 25 on Your Calendar!
|
|
Fall Lupus Medical Conference
C. Michael Neuwelt, MD, Professor of Medicine at UCSF, will headline the conference.
Dr. Neuwelt is a clinical professor of Medicine at the University of California San Francisco, Chief of Rheumatology at Alameda County Medical Center in Oakland and Director of Rheumatology Core Curriculum at St. Mary's Medical Center in San Francisco. He has been challenged and fascinated by Systemic Lupus Erythematosus (SLE) since 1973 during his third year of medical school. This challenge has persisted in his private clinical practice and teaching at a county hospital since 1979. Dr. Neuwelt will discuss latest trends in disease management of lupus and present an update on several lupus research projects he is involved in.
The conference will also feature a presentation on the psychological problems commonly associated with SLE by LFNC Board Member and pain psychology therapist, Sarah S. Goozee, Ph.D.
Date: Saturday, November 9, 2013
Time: 11 am to 4 pm
Venue: Sutter Health Alta Bates Summit Medical Center. 350 Hawthorne Ave, Oakland, CA 94609
Registration: Please register online or complete the form on the back of this flyer and mail or fax it with your payment to the LFNC.
Fee: $50 for California Registered Nurses (5 CEU credits) | $30 for non-credit attendees. Includes refreshments; Current LFNC members are entitled to $10 off the registration fee.
The Lupus Foundation of Northern California wishes to thank the following for their assistance in making this conference possible: Lupus Research Institute and GlaxoSmithKline.
|
|
|
|
|
|
|
